Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia.

@article{Suzuki2007ColestimideLP,
  title={Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia.},
  author={Tatsuya Suzuki and Kenzo Oba and Yoshimasa Igari and Noriaki Matsumura and Kentaro Watanabe and Shoko Futami-Suda and Hiroko Yasuoka and Motoshi Ouchi and Kazunari Suzuki and Yoshiaki Kigawa and Hiroshi Nakano},
  journal={Journal of Nippon Medical School = Nippon Ika Daigaku zasshi},
  year={2007},
  volume={74 5},
  pages={338-43}
}
BACKGROUND Colestimide has been reported to lower blood glucose levels in patients with type 2 diabetes complicated by hypercholesterolemia. AIM To examine the mechanism by which colestimide decreases plasma glucose levels in the above patients. METHODS A total of 16 inpatients with type 2 diabetes complicated by hypercholesterolemia received colestimide for 1 week after their plasma glucose levels stabilized. We measured plasma glucose, serum immunoreactive insulin (IRI), serum lipid… CONTINUE READING

From This Paper

Figures and tables from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.

Obesity reviews : an official journal of the International Association for the Study of Obesity • 2011
View 13 Excerpts
Highly Influenced

Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.

The Journal of pharmacology and experimental therapeutics • 2010
View 1 Excerpt
Highly Influenced

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs.

Diabetes therapy : research, treatment and education of diabetes and related disorders • 2016
View 1 Excerpt

The role of bile acids in metabolic regulation.

The Journal of endocrinology • 2016
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 20 references

( abstract )

M .Watanabe, SM Houten, C Mataki
2006

Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme • 2002

Glucagon - like peptide - 1 response to acarbose in elderly type 2 diabetic subjects

C .Herrmann, R Goke, +3 authors B Goke
Diabetes Research and Clinical Practice • 2002

Determinants of the impaired secretion of glucagon - like peptide - 1 in type 2 diabetic patients

E .Mannucci, A Ognibene, F Cremasco
J Clin Endocrinol Metab • 2001

Similar Papers

Loading similar papers…